Hoosiers Work For Health Partners

• Bayer
• Bloomington Chamber of Commerce
• Carmel Chamber of Commerce
• The City of Bicknell, IN
• The City of Bloomington, IN
• The City of Hammond, IN
• The City of Huntington, IN
• The City of Linton, IN
  
• The City of Loogootee, IN
• The City of Mitchell, IN
• The City of Oakland City, IN
• The City of Petersburg, IN
• The City of Washington, IN
• The City of Vincennes, IN
  
• Decatur Chamber of Commerce
• Epilepsy Foundation of Kentuckiana
  
• Goodwill Industries of Indiana
• Greater Indianapolis Chamber of Commerce
• Eli Lilly and Company
• Fort Wayne Chamber of Commerce
• Indiana Association of Cities and Towns (IACT)
• Indiana Economic Development Association (IDEA)
• Indiana Health Industry Forum
• Indiana Hispanic Chamber of Commerce
  
• Indiana Latino Institute
  
• Indiana Minority Supplier Diversity Council
• Indiana Sheet Metal Workers
• Indiana State Chamber of Commerce
  
• Indiana State Dept. of Health Diabetes Prevention and Control Program
  
• Indiana Urban and Rural Health Network
• Indianapolis Economic Development
• Jackson County United Way
• Indiana Minority Health Coalition
  
• Jefferson County United Way, Inc.
• Mental Health America of Indiana
• National Alliance on Mental Illness (NAMI) Indiana
• National Kidney Foundation of Indiana
• One Southern Indiana
  
• Pfizer
  
• PhRMA
• Roche Diagnostics
• United Way of Central Indiana

Industry Impact

America’s biopharmaceutical sector helps to research, manufacture, distribute and promote innovative therapies that make a critical difference in the lives of millions of people. In the last ten years, scientists have discovered and developed more than 300 completely new medicines, vaccines and biologics approved by FDA.

The value of this sector, however, extends beyond life-enhancing advancements in medicine and includes great contributions to our national and state economies. As vital economic partners, biopharmaceutical companies generate tax revenue, create high-paying jobs and provide growth opportunities for related industries and domestic labor. In fact:

• The industry provides jobs in all 50 states, Washington, D.C., and Puerto Rico. States in which the national biopharmaceutical sector supported the largest number of jobs in 2006 included: California, New York, New Jersey, Pennsylvania, and Illinois.
• The industry directly provided 686,422 jobs in 2006 and supported an estimated 3.2 million jobs across the U.S. economy when accounting its full ripple effect (i.e., direct, indirect, and induced jobs).
• The industry’s direct contribution to the GDP in 2006, $88.5 billion, was triple the average contribution from sectors in the rest of the economy. For every dollar the industry contributed to the GDP in 2006, the ripple effect of that activity supported another $2.33 in contribution to the GDP from other sectors.
• In 2006, U.S. Biopharmaceutical companies invested $56.1 billion in research and development for new medicines.

In addition, many biopharmaceutical companies provide philanthropic assistance in their local communities through support of access to affordable products, education, social services, arts and other community needs.

The biopharmaceutical sector is creating the momentum to protect and foster innovation and scientific discovery. These groups are working together to continue advancements in medical innovation and ensure its future in the United States. They recognize the value of our country’s ability to innovate and are taking steps to preserve America’s leadership in order to remain competitive in the global environment.

The biopharmaceutical sector is committed to helping Americans lead longer, healthier lives and are steadfastly working to strengthen the economy.

To learn more, download the following report: The Biopharmaceutical Sector’s Impact on the U.S. Economy: Analysis at the National, State, and Local Levels by Archstone Consulting